The acute treatment of migraine with transnasal butorphanol (TNB)
|
Freitag F. |
1993 |
Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
|
Alemdar M., Pekdemir M., Selekler HM. |
2007 |
Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack.
|
Boureau F., Joubert JM., Lasserre V., Prum B., Delecoeuillerie G. |
1994 |
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
|
Carleton SC., Shesser RF., Pietrzak MP., Chudnofsky CR., Starkman S., Morris DL., Johnson G., Rhee KJ., Barton CW., Chelly JE., Rosenberg J., Van Valen MK. |
1998 |
Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.
|
Friedman BW., Irizarry E., Solorzano C., Latev A., Rosa K., Zias E., Vinson DR., Bijur PE., Gallagher EJ. |
2017 |
Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache.
|
Griffith JD., Mycyk MB., Kyriacou DN. |
2008 |
Transnasal butorphanol in the treatment of acute migraine.
|
Hoffert MJ., Couch JR., Diamond S., Elkind AH., Goldstein J., Kohlerman NJ., Saper JR., Solomon S. |
1995 |
Current emergency treatment of severe migraine headaches.
|
Klapper JA., Stanton J. |
-- Not Found -- |
Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache.
|
Lane PL., McLellan BA., Baggoley CJ. |
1989 |
A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache.
|
Richman PB., Allegra J., Eskin B., Doran J., Reischel U., Kaiafas C., Nashed AH. |
2002 |
Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.
|
Scherl ER., Wilson JF. |
1995 |
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
|
Silberstein SD., Freitag FG., Rozen TD., Kudrow DB., Hewitt DJ., Jordan DM., Fisher AC., Rosenthal NR. |
-- Not Found -- |
Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial.
|
Stiell IG., Dufour DG., Moher D., Yen M., Beilby WJ., Smith NA. |
1991 |
Intravenous dexamethasone versus morphine in relieving of acute migraine headache.
|
Taheraghdam AA., Amiri H., Shojaan H., Shamsvahdati S., Houshyar Y. |
2011 |
Narcotic analgesics for acute migraine in the emergency room: are we meeting Headache Societies' guidelines?
|
Wasay M., Zaki KS., Khan SU., Rehmani R. |
2006 |
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.
|
Aggarwal D., Heim AJ., Bittel B., Ford D., Dubinsky R., Gronseth G., Hairston V., Landazuri P., Sachen F., Herbelin L., Barohn RJ. |
2020 |
Comparison of granisetron and metoclopramide in the treatment of pain and emesis in migraine patients: A randomized controlled trial study.
|
Amiri H., Ghodrati N., Nikuyeh M., Shams-Vahdati S., Jalilzadeh-Binazar M. |
2017 |
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Aurora SK., Silberstein SD., Kori SH., Tepper SJ., Borland SW., Wang M., Dodick DW. |
2011 |
A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
|
Aurora SK., Rozen TD., Kori SH., Shrewsbury SB. |
2009 |
Intranasal Lidocaine in Acute Treatment of Migraine: A Randomized Controlled Trial.
|
Avcu N., Doğan NÖ., Pekdemir M., Yaka E., Yılmaz S., Alyeşil C., Akalın LE. |
2017 |
Propranolol in the treatment of acute migraine attacks.
|
Banerjee M., Findley L. |
1991 |
Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study.
|
Baratloo A., Mirbaha S., Delavar Kasmaei H., Payandemehr P., Elmaraezy A., Negida A. |
2017 |
A comparative trial of three agents in the treatment of acute migraine headache.
|
Bell R., Montoya D., Shuaib A., Lee MA. |
1990 |
Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study.
|
Bigal ME., Bordini CA., Tepper SJ., Speciali JG. |
2002 |
Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial.
|
Bigal ME., Bordini CA., Speciali JG. |
2002 |
Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.
|
Bigal ME., Bordini CA., Tepper SJ., Speciali JG. |
2002 |
Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study.
|
Bigal ME., Bordini CA., Speciali JG. |
2001 |
Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial.
|
Blanda M., Rench T., Gerson LW., Weigand JV. |
2001 |
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
|
Brandes JL., Klise S., Krege JH., Case M., Khanna R., Vasudeva R., Raskin J., Pearlman EM., Kudrow D. |
2019 |
A controlled study of dihydroergotamine in the treatment of acute migraine headache.
|
Callaham M., Raskin N. |
1986 |
Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache.
|
Cameron JD., Lane PL., Speechley M. |
1995 |
A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
|
Cete Y., Dora B., Ertan C., Ozdemir C., Oktay C. |
2005 |
Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine.
|
Chappell AS., Bay JM., Botzum GD., Cohen ML. |
-- Not Found -- |
Randomized, controlled trial of telcagepant for the acute treatment of migraine.
|
Connor KM., Shapiro RE., Diener HC., Lucas S., Kost J., Fan X., Fei K., Assaid C., Lines C., Ho TW. |
2009 |
Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.
|
Coppola M., Yealy DM., Leibold RA. |
1995 |
Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
|
Corbo J., Esses D., Bijur PE., Iannaccone R., Gallagher EJ. |
2001 |
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
|
Croop R., Goadsby PJ., Stock DA., Conway CM., Forshaw M., Stock EG., Coric V., Lipton RB. |
2019 |
Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
|
Dahlöf CG., Hauge AW., Olesen J. |
2009 |
Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks.
|
Demirkaya S., Vural O., Dora B., Topçuoğlu MA. |
2001 |
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
|
Derosier F., Sheftell F., Silberstein S., Cady R., Ruoff G., Krishen A., Peykamian M. |
2012 |
Double-blind controlled study of paramax in the acute treatment of common and classical migraine.
|
Dexter SL., Graham AN., Johnston ES., Ratcliffe DM., Wilkinson MI., Rose AJ. |
1985 |
Intranasal civamide for the acute treatment of migraine headache.
|
Diamond S., Freitag F., Phillips SB., Bernstein JE., Saper JR. |
2000 |
Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial.
|
Diamond S. |
1976 |
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study.
|
Diener HC., Barbanti P., Dahlöf C., Reuter U., Habeck J., Podhorna J. |
2011 |
RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks.
|
Diener HC. |
2003 |
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
|
Diener HC., Jansen JP., Reches A., Pascual J., Pitei D., Steiner TJ. |
2002 |
Ubrogepant for the Treatment of Migraine.
|
Dodick DW., Lipton RB., Ailani J., Lu K., Finnegan M., Trugman JM., Szegedi A. |
2019 |
Intravenous metoclopramide in the treatment of acute migraines: A randomized, placebo-controlled trial.
|
Doğan NÖ., Pekdemir M., Yılmaz S., Yaka E., Karadaş A., Durmuş U., Avcu N., Koçkan E. |
2019 |
Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
|
Donaldson D., Sundermann R., Jackson R., Bastani A. |
2008 |
Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial.
|
Etchison AR., Bos L., Ray M., McAllister KB., Mohammed M., Park B., Phan AV., Heitz C. |
2018 |
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study.
|
Färkkilä M., Diener HC., Géraud G., Láinez M., Schoenen J., Harner N., Pilgrim A., Reuter U. |
2012 |
Buccally absorbed vs intravenous prochlorperazine for treatment of migraines headaches.
|
Fernando T., Lumanauw DD., Youn S., Shimada M., Yadav K., Chappell B., Horeczko T., Tanen DA. |
2019 |
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.
|
Ferrari MD., Färkkilä M., Reuter U., Pilgrim A., Davis C., Krauss M., Diener HC. |
2010 |
Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder.
|
Foroughipour M., Ghandehari K., Khazaei M., Ahmadi F., Shariatinezhad K., Ghandehari K. |
2013 |
A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide.
|
Friedman BW., Mohamed S., Robbins MS., Irizarry E., Tarsia V., Pearlman S., John Gallagher E. |
2018 |
Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial.
|
Friedman BW., Cabral L., Adewunmi V., Solorzano C., Esses D., Bijur PE., Gallagher EJ. |
2016 |
Metoclopramide for acute migraine: a dose-finding randomized clinical trial.
|
Friedman BW., Mulvey L., Esses D., Solorzano C., Paternoster J., Lipton RB., Gallagher EJ. |
2011 |
A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
|
Friedman BW., Esses D., Solorzano C., Dua N., Greenwald P., Radulescu R., Chang E., Hochberg M., Campbell C., Aghera A., Valentin T., Paternoster J., Bijur P., Lipton RB., Gallagher EJ. |
2008 |
Randomized trial of IV dexamethasone for acute migraine in the emergency department.
|
Friedman BW., Greenwald P., Bania TC., Esses D., Hochberg M., Solorzano C., Corbo J., Chu J., Chew E., Cheung P., Fearon S., Paternoster J., Baccellieri A., Clark S., Bijur PE., Lipton RB., Gallagher EJ. |
2007 |
Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo.
|
Friedman AP., Di Serio FJ., Hwang DS. |
1989 |
A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department.
|
Gaffigan ME., Bruner DI., Wason C., Pritchard A., Frumkin K. |
2015 |
Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
|
Gallagher RM. |
1996 |
Postdischarge secobarbital after ED migraine treatment decreases pain and improves resolution.
|
Gerhardt RT., Hermstad E., Crawford DM., Rayfield J., Pfaff J., Hunter CJ. |
2011 |
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.
|
Goadsby PJ., Wietecha LA., Dennehy EB., Kuca B., Case MG., Aurora SK., Gaul C. |
2019 |
Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.
|
Goldstein DJ., Wang O., Saper JR., Stoltz R., Silberstein SD., Mathew NT. |
1997 |
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.
|
Gomez-Mancilla B., Cutler NR., Leibowitz MT., Spierings EL., Klapper JA., Diamond S., Goldstein J., Smith T., Couch JR., Fleishaker J., Azie N., Blunt DE. |
2001 |
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
|
Gomez-Mancilla B., Brand R., Jürgens TP., Göbel H., Sommer C., Straube A., Evers S., Sommer M., Campos V., Kalkman HO., Hariry S., Pezous N., Johns D., Diener HC. |
2014 |
Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks.
|
Hakkarainen H., Allonen H. |
1982 |
Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine.
|
Hewitt DJ., Martin V., Lipton RB., Brandes J., Ceesay P., Gottwald R., Schaefer E., Lines C., Ho TW. |
2011 |
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
|
Hewitt DJ., Aurora SK., Dodick DW., Goadsby PJ., Ge YJ., Bachman R., Taraborelli D., Fan X., Assaid C., Lines C., Ho TW. |
2011 |
Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
|
Ho TW., Ho AP., Chaitman BR., Johnson C., Mathew NT., Kost J., Fan X., Aurora SK., Brandes JL., Fei K., Beebe L., Lines C., Krucoff MW. |
2012 |
Randomized, controlled trial of telcagepant over four migraine attacks.
|
Ho AP., Dahlöf CG., Silberstein SD., Saper JR., Ashina M., Kost JT., Froman S., Leibensperger H., Lines CR., Ho TW. |
2010 |
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
|
Ho TW., Ferrari MD., Dodick DW., Galet V., Kost J., Fan X., Leibensperger H., Froman S., Assaid C., Lines C., Koppen H., Winner PK. |
2008 |
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.
|
Ho TW., Mannix LK., Fan X., Assaid C., Furtek C., Jones CJ., Lines CR., Rapoport AM. |
2008 |
A double-blind controlled study of nifedipine as an abortive treatment in acute attacks of migraine with aura.
|
Hoffert MJ., Scholz MJ., Kanter R. |
1992 |
Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
|
Honkaniemi J., Liimatainen S., Rainesalo S., Sulavuori S. |
2006 |
The nitric oxide synthase inhibitor and serotonin-receptor agonist NXN-188 during the aura phase of migraine with aura: A randomized, double-blind, placebo-controlled cross-over study.
|
Hougaard A., Hauge AW., Guo S., Tfelt-Hansen P. |
2013 |
Intravenous Fluid for the Treatment of Emergency Department Patients With Migraine Headache: A Randomized Controlled Trial.
|
Jones CW., Remboski LB., Freeze B., Braz VA., Gaughan JP., McLean SA. |
2019 |
Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department.
|
Jones EB., Gonzalez ER., Boggs JG., Grillo JA., Elswick RK. |
1994 |
Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.
|
Jones J., Pack S., Chun E. |
1996 |
Ketoprofen and ergotamine in acute migraine.
|
Kangasniemi P., Kaaja R. |
1992 |
Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995).
|
Kapicioğlu S., Gökce E., Kapicioğlu Z., Ovali E. |
1997 |
Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial.
|
Karimi N., Tavakoli M., Charati JY., Shamsizade M. |
2017 |
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
|
Kuca B., Silberstein SD., Wietecha L., Berg PH., Dozier G., Lipton RB. |
2018 |
Octreotide is not effective in the acute treatment of migraine.
|
Levy MJ., Matharu MS., Bhola R., Meeran K., Goadsby PJ. |
2005 |
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
|
Lipton RB., Croop R., Stock EG., Stock DA., Morris BA., Frost M., Dubowchik GM., Conway CM., Coric V., Goadsby PJ. |
2019 |
Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
|
Lipton RB., Stewart WF., Ryan RE., Saper J., Silberstein S., Sheftell F. |
1998 |
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
|
Lipton RB., Dodick DW., Ailani J., Lu K., Finnegan M., Szegedi A., Trugman JM. |
2019 |
Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study.
|
Loisy C., Beorchia S., Centonze V., Fozard JR., Schechter PJ., Tell GP. |
1985 |
Intranasal lidocaine for migraine: a randomized trial and open-label follow-up.
|
Maizels M., Geiger AM. |
1999 |
Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial.
|
Maizels M., Scott B., Cohen W., Chen W. |
-- Not Found -- |
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
|
Marcus R., Goadsby PJ., Dodick D., Stock D., Manos G., Fischer TZ. |
2014 |
Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial.
|
Mazaheri S., Poorolajal J., Hosseinzadeh A., Fazlian MM. |
2015 |
Treatment of migraine with intramuscular chlorpromazine.
|
McEwen JI., O'Connor HM., Dinsdale HB. |
1987 |
Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache.
|
Miller MA., Levsky ME., Enslow W., Rosin A. |
2009 |
Clinical trial of flupirtine maleate in patients with migraine.
|
Million R., Finlay BR., Whittington JR. |
1984 |
The effect of intravenous verapamil on acute migraine headache.
|
Molaie M., Olson CM., Koch J. |
1987 |
Flunarizine (10 and 20 mg) i.v. versus placebo in the treatment of acute migraine attacks: a multi-centre double-blind study.
|
Pfaffenrath V., Oestreich W., Haase W. |
1990 |
A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache.
|
Prior MJ., Codispoti JR., Fu M. |
2010 |
Comparing the Effect of Intranasal Lidocaine 4% with Peppermint Essential Oil Drop 1.5% on Migraine Attacks: A Double-Blind Clinical Trial.
|
Rafieian-Kopaei M., Hasanpour-Dehkordi A., Lorigooini Z., Deris F., Solati K., Mahdiyeh F. |
2019 |
Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
|
-- Not Found -- |
1995 |
Is intravenous lidocaine clinically effective in acute migraine?
|
Reutens DC., Fatovich DM., Stewart-Wynne EG., Prentice DA. |
1991 |
A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department.
|
Rowat BM., Merrill CF., Davis A., South V. |
1991 |
Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache.
|
Ryan RE. |
1970 |
Metoclopramide as an analgesic in severe migraine attacks: an open, single-blind, parallel control study.
|
Salazar G., Fragoso M., Vergez L., Sergio P., Cuello D. |
2011 |
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
|
Sang CN., Ramadan NM., Wallihan RG., Chappell AS., Freitag FG., Smith TR., Silberstein SD., Johnson KW., Phebus LA., Bleakman D., Ornstein PL., Arnold B., Tepper SJ., Vandenhende F. |
2004 |
Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache.
|
Shahrami A., Assarzadegan F., Hatamabadi HR., Asgarzadeh M., Sarehbandi B., Asgarzadeh S. |
2015 |
Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine.
|
Sharma S., Prasad A., Nehru R., Anand KS., Rishi RK., Chaturvedi S., Bapna JS., Sharma DR. |
2002 |
Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial.
|
Silberstein SD., Young WB., Mendizabal JE., Rothrock JF., Alam AS. |
2003 |
Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.
|
Silberstein SD., Schoenen J., Göbel H., Diener HC., Elkind AH., Klapper JA., Howard RA. |
2009 |
Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial.
|
Soleimanpour H., Ghafouri RR., Taheraghdam A., Aghamohammadi D., Negargar S., Golzari SE., Abbasnezhad M. |
2012 |
Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial.
|
Soyka D., Taneri Z., Oestreich W., Schmidt R. |
1989 |
Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study.
|
Soyka D., Taneri Z., Oestreich W., Schmidt R. |
1988 |
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
|
Swidan SZ., Lake AE., Saper JR. |
2005 |
Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
|
Tanen DA., Miller S., French T., Riffenburgh RH. |
2003 |
A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department.
|
Tek DS., McClellan DS., Olshaker JS., Allen CL., Arthur DC. |
1990 |
Dihydroergotamine nasal spray in the treatment of acute migraine.
|
Treves TA., Kuritzky A., Hering R., Korczyn AD. |
1998 |
The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study.
|
Tulunay FC., Ergün H., Gülmez SE., Ozbenli T., Ozmenoğlu M., Boz C., Erdemoglu AK., Varlikbas A., Göksan B., Inan L. |
-- Not Found -- |
Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.
|
Tulunay FC., Karan O., Aydin N., Culcuoglu A., Guvener A. |
1987 |
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
|
Voss T., Lipton RB., Dodick DW., Dupre N., Ge JY., Bachman R., Assaid C., Aurora SK., Michelson D. |
2016 |
Dihydroergotamine nasal spray for the acute treatment of migraine.
|
Ziegler D., Ford R., Kriegler J., Gallagher RM., Peroutka S., Hammerstad J., Saper J., Hoffert M., Vogel B., Holtz N. |
1994 |
Propofol for migraine in the emergency department: A pilot randomised controlled trial.
|
Mitra B., Roman C., Mercier E., Moloney J., Yip G., Khullar K., Walsh K., Smit V., Cameron PA. |
2020 |
Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study.
|
Borhani Haghighi A., Motazedian S., Rezaii R., Mohammadi F., Salarian L., Pourmokhtari M., Khodaei S., Vossoughi M., Miri R. |
2010 |
Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
|
Chou DE., Shnayderman Yugrakh M., Winegarner D., Rowe V., Kuruvilla D., Schoenen J. |
2019 |
Pain Management Using Acupuncture Method in Migraine Headache Patients; A Single Blinded Randomized Clinical Trial.
|
Farahmand S., Shafazand S., Alinia E., Bagheri-Hariri S., Baratloo A. |
2018 |
Treatment of acute migraine by a partial rebreathing device: A randomized controlled pilot study.
|
Fuglsang CH., Johansen T., Kaila K., Kasch H., Bach FW. |
2018 |
Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial.
|
Hokenek NM., Erdogan MO., Hokenek UD., Algin A., Tekyol D., Seyhan AU. |
2020 |
The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments.
|
Korucu O., Dagar S., Çorbacioglu ŞK., Emektar E., Cevik Y. |
2018 |
Acupuncture for treating acute attacks of migraine: a randomized controlled trial.
|
Li Y., Liang F., Yang X., Tian X., Yan J., Sun G., Chang X., Tang Y., Ma T., Zhou L., Lan L., Yao W., Zou R. |
2009 |
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
Lipton RB., Dodick DW., Silberstein SD., Saper JR., Aurora SK., Pearlman SH., Fischell RE., Ruppel PL., Goadsby PJ. |
2010 |
Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial.
|
Niazi M., Hashempur MH., Taghizadeh M., Heydari M., Shariat A. |
2017 |
Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial.
|
Sasannejad P., Saeedi M., Shoeibi A., Gorji A., Abbasi M., Foroughipour M. |
2012 |
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
|
Tassorelli C., Grazzi L., de Tommaso M., Pierangeli G., Martelletti P., Rainero I., Dorlas S., Geppetti P., Ambrosini A., Sarchielli P., Liebler E., Barbanti P. |
2018 |
Nitrous oxide for the treatment of acute migraine headache.
|
Triner WR., Bartfield JM., Birdwell M., Raccio-Robak N. |
1999 |
Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled trial.
|
Wang LP., Zhang XZ., Guo J., Liu HL., Zhang Y., Liu CZ., Yi JH., Wang LP., Zhao JP., Li SS. |
2012 |
A PET-CT study on the specificity of acupoints through acupuncture treatment in migraine patients.
|
Yang J., Zeng F., Feng Y., Fang L., Qin W., Liu X., Song W., Xie H., Chen J., Liang F. |
2012 |
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
|
Yarnitsky D., Dodick DW., Grosberg BM., Burstein R., Ironi A., Harris D., Lin T., Silberstein SD. |
2019 |
Nonpainful remote electrical stimulation alleviates episodic migraine pain.
|
Yarnitsky D., Volokh L., Ironi A., Weller B., Shor M., Shifrin A., Granovsky Y. |
2017 |
Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study.
|
Zargaran A., Borhani-Haghighi A., Salehi-Marzijarani M., Faridi P., Daneshamouz S., Azadi A., Sadeghpour H., Sakhteman A., Mohagheghzadeh A. |
2018 |
Phase 1 of integrated EMDR: An abortive treatment for migraine headaches
|
Marcus S |
2008 |
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
|
Ashcroft DM., Millson D. |
2004 |
Zolmitriptan for acute migraine attacks in adults.
|
Bird S., Derry S., Moore RA. |
2014 |
Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
|
Chen LC., Ashcroft DM. |
2007 |
Sumatriptan (oral route of administration) for acute migraine attacks in adults.
|
Derry CJ., Derry S., Moore RA. |
2012 |
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.
|
Derry CJ., Derry S., Moore RA. |
2012 |
Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
|
Ferrari MD., Loder E., McCarroll KA., Lines CR. |
2001 |
Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
|
Mandema JW., Cox E., Alderman J. |
2005 |
Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.
|
Menshawy A., Ahmed H., Ismail A., Abushouk AI., Ghanem E., Pallanti R., Negida A. |
2018 |
Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
|
Poolsup N., Leelasangaluk V., Jittangtrong J., Rithlamlert C., Ratanapantamanee N., Khanthong M. |
2005 |
Diclofenac with or without an antiemetic for acute migraine headaches in adults.
|
Derry S., Rabbie R., Moore RA. |
2012 |
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults.
|
Derry S., Moore RA. |
2013 |
Aspirin with or without an antiemetic for acute migraine headaches in adults.
|
Kirthi V., Derry S., Moore RA., McQuay HJ. |
2010 |
Ibuprofen with or without an antiemetic for acute migraine headaches in adults.
|
Rabbie R., Derry S., Moore RA., McQuay HJ. |
2010 |
Ketorolac in the treatment of acute migraine: a systematic review.
|
Taggart E., Doran S., Kokotillo A., Campbell S., Villa-Roel C., Rowe BH. |
2013 |
Sumatriptan plus naproxen for acute migraine attacks in adults.
|
Law S., Derry S., Moore RA. |
2013 |
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
|
Xu H., Han W., Wang J., Li M. |
2016 |